跳至主要内容
临床试验/ISRCTN48682427
ISRCTN48682427已完成不适用

Directly Observed antiretroviral Therapy for people living with Human Immunodeficiency Virus (HIV) and Acquired ImmunDeficiency Syndrome (AIDS): a randomised controlled trial

Ministry of Health (Brazil)0 个研究点目标入组 0 人开始时间: 2004年3月2日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. HIV-1 infected individuals
  • 2. 18 years old or older
  • 3. Starting antiretroviral therapy in three AIDS clinics in Porto Alegre (Brazil)

排除标准

  • Not provided at time of registration

研究者

发起方
Ministry of Health (Brazil)

相似试验

已完成
不适用
Highly active anti-retroviral therapy including nevirapine once daily versus twice daily after at least 12 weeks of nevirapine twice daily. A randomized, open, multicentre trial.
ISRCTN81305260Institute of Biomedical Investigations of Bellvitge (Institut d'Investigació Biomèdica de Bellvitge) (IDIBELL) (Spain)308
进行中(未招募)
1 期
Initiation of first-line antiretroviral treatment with TENOFOVIR ALAFENAMIDE - EMTRICITABINE - BICTEGRAVIR at the first clinical contact in France: Trial IMEA 055 – FASTHIV positive age > 18 years -newly diagnosed HIV-infected individual evidenced by any tests -antiretroviral-treatment naive -negative urine pregnancy test -willing to sign an informed written consent– -regular health insurance -willing to provide two distinct contact information (telephone number and/or email) in order to be easily reached if needed between Day 0 and Day 7
EUCTR2019-000812-27-FRIMEA110
已完成
不适用
Highly Active Antiretroviral Treatment (HAART) of Human Immunodeficiency Virus (HIV)-infection in a town in Cameroon: randomised controlled study to suggest which treatment starting point is most beneficial for the patientsHIV infectionInfections and InfestationsHIV
ISRCTN22114173Institute of Community Medicine, University of Tromsø (Norway)100
尚未招募
1 期
Immunological and Virucidal effect of Amrita Tablet for Prevention of HIV AIDS
CTRI/2024/01/062079Satyananda yoga and Ayurveda Research institute Motihari
进行中(未招募)
1 期
Short pulse antiretroviral therapy at HIV seroconversion:A multi-centre randomised trial of therapeutic intervention at primary HIV-1 infection. Tratamiento antirretroviral en pulsos cortos en la seroconversión por el VIH: ensayo clínico aleatorizado, multicéntrico, de intervención terapéutica en la infección primaria por VIH-1. - SPARTACprimary HIV infection infección primaria por el VIHMedDRA version: 9.1 Level: LLT Classification code 10058427 Term: Primary HIV infection
EUCTR2004-000446-20-ESImperial College371
Directly Observed antiretroviral Therapy for people... | 临床试验